Alveo Technologies and Global Animal Health Partner to Deploy National-Scale Molecular Avian Influenza Surveillance Across Egypt
December 18, 2025
Lyric Bio, Inc. Closes $6.6 Million Seed Financing To Revolutionize Donor-Derived Therapeutics
December 2, 2025
Engage3 Renews SOC 2 Type II Compliance, Strengthening Commitment to Data Security and Trust
October 30, 2025
Joint Genome Institute Demonstrates Feasibility of Alveo Technologies’ Portable Molecular Testing Platform for Wastewater Pathogen Surveillance
October 23, 2025
Ares Materials Announces First Close to its Series B Financing to Accelerate AI-Driven Materials Innovation
October 9, 2025
Prellis Biologics Enters Multi-Target Drug Discovery & Development Collaboration with Lilly to Advance Human Antibody Therapeutics
September 23, 2025
Innova Vascular Founder & CEO Dr. Sanjay Shrivastava, Ph.D. Featured at LSIEurope
September 11, 2025
Alveo Technologies Successfully Fulfills Expanded CDC Milestone Agreement to Advance its Rapid Molecular Test for both Seasonal and Avian Influenza A(H5) in Humans
August 26, 2025
